Funda Yetkin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Funda Yetkin has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Sarıcı
Division of Hematology, Department of Internal Medicine, Faculty of Medicine, İnönü University, 44280 Malatya, Türkiye
3 shared publications - Baris Otlu
Department of Medical Microbiology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye
3 shared publications - Elif Seren Tanrıverdi
Department of Medical Microbiology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye
3 shared publications - Emin Kaya
Division of Hematology, Department of Internal Medicine, Faculty of Medicine, İnönü University, 44280 Malatya, Türkiye
3 shared publications - Ilhami Berber
Division of Hematology, Department of Internal Medicine, Faculty of Medicine, İnönü University, 44280 Malatya, Türkiye
3 shared publications - İrFan Kuku
Division of Hematology, Department of Internal Medicine, Faculty of Medicine, İnönü University, 44280 Malatya, Türkiye
3 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2615
Early Bacterial Bloodstream Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Microbiology and Outcomes in a Single Turkish Center
Background/Objectives: Bloodstream infections (BSIs) are a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), and reported incidence depends on how skin commensals are adjudicated. We describe the epidemiology, microbiology, risk factors, and survival impact of early (day 0–30) bacterial BSI at a Turkish transplant center. Methods: We retrospectively studied 155 consecutive allo-HSCT episodes in 153 adults (April 2017–January 2026). Single-isolate coagulase-negative staphylococci (CoNS) were classified as contaminants. Cumulative incidence was estimated with the Aalen–Johansen estimator and survival with day-30 landmark and time-dependent Cox models. Results: Bacterial BSI occurred in 20 episodes (30-day cumulative incidence 12.9%, 95% CI 8.2–18.7) at a median of 14 days; counting single-isolate CoNS would have raised incidence to 40.0%. Of 22 isolates, 15 (68.2%) were Gram-negative and 12 (54.5%) were Escherichia coli. An extended-spectrum β-lactamase phenotype was present in nine episodes. Among 14 Gram-negative episodes with susceptibility data, 71.4% were fluoroquinolone-resistant and 92.9% meropenem-susceptible; empirical therapy was active in 16 of 20 episodes (80.0%). No baseline covariate predicted BSI, and early BSI was not associated with overall survival (adjusted HR 0.75, 95% CI 0.34–1.64). Conclusions: Early bacterial BSI was predominantly Gram-negative and E. coli-driven, with frequent fluoroquinolone resistance but preserved carbapenem susceptibility. Contaminant adjudication substantially altered incidence and should be stated explicitly.
- 12 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2615
Open AccessEarly Bacterial Bloodstream Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Microbiology and Outcomes in a Single Turkish Center
Background/Objectives: Bloodstream infections (BSIs) are a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), and reported incidence depends on how skin commensals are adjudicated. We describe the epidemiology, microbiology, risk factors, and survival impact of early (day 0–30) bacterial BSI at a Turkish transplant center. Methods: We retrospectively studied 155 consecutive allo-HSCT episodes in 153 adults (April 2017–January 2026). Single-isolate coagulase-negative staphylococci (CoNS) were classified as contaminants. Cumulative incidence was estimated with the Aalen–Johansen estimator and survival with day-30 landmark and time-dependent Cox models. Results: Bacterial BSI occurred in 20 episodes (30-day cumulative incidence 12.9%, 95% CI 8.2–18.7) at a median of 14 days; counting single-isolate CoNS would have raised incidence to 40.0%. Of 22 isolates, 15 (68.2%) were Gram-negative and 12 (54.5%) were Escherichia coli. An extended-spectrum β-lactamase phenotype was present in nine episodes. Among 14 Gram-negative episodes with susceptibility data, 71.4% were fluoroquinolone-resistant and 92.9% meropenem-susceptible; empirical therapy was active in 16 of 20 episodes (80.0%). No baseline covariate predicted BSI, and early BSI was not associated with overall survival (adjusted HR 0.75, 95% CI 0.34–1.64). Conclusions: Early bacterial BSI was predominantly Gram-negative and E. coli-driven, with frequent fluoroquinolone resistance but preserved carbapenem susceptibility. Contaminant adjudication substantially altered incidence and should be stated explicitly.
- Open Access
- 28 October 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1694
Documented Infections and Mortality in Patients Receiving Bruton Tyrosine Kinase Inhibitors: A Single-Center Retrospective Cohort of B-Cell Malignancies and Chronic Graft-Versus-Host Disease
Background/Objectives: Infection burden during Bruton tyrosine kinase inhibitor (BTKi) treatment is difficult to interpret when infection onset, treatment initiation, and discontinuation are incompletely documented. We described the timing, microbiology, and mortality of documented infections and explored the association between peri-initiation albumin and documented infection. Methods: This retrospective single-center cohort included 76 patients treated with ibrutinib or acalabrutinib for B-cell malignancies or chronic graft-versus-host disease (cGVHD). The first documented on-treatment infection was analyzed using Aalen–Johansen cumulative incidence, with death or permanent treatment discontinuation as competing events. Sensitivity analyses included a day-30 landmark analysis, a total-burden analysis that also counted infections after discontinuation, and indication-specific estimates. Albumin associations were assessed through day 90, with Benjamini–Hochberg correction across seven exploratory comparisons. Results: Fifty-eight patients had B-cell malignancies and 18 had cGVHD; median follow-up by reverse Kaplan–Meier was 244 days. A qualifying infection occurred in 27/76 patients (35.5%); 17/27 were recorded within 30 days, of which one was suggestive of pre-existing infection and 16 were indeterminate. The cumulative incidence at day 180 was 30.5% (95% CI 19.9–41.5%) on treatment and 38.1% (95% CI 26.2–50.4%) when post-discontinuation infections were included. Among 49 patients still eligible at day 30, the conditional incidence by original day 180 was 11.2% (95% CI 2.4–21.3%). Respiratory and urinary foci accounted for 13/27 and 9/27 infections, respectively. Twenty-nine patients (38.2%) died; 17/29 deaths were recorded as infection-related. Median albumin was lower in patients with infection by day 90 (3.05 versus 3.80 g/dL; nominal p = 0.009), but this exploratory difference did not meet the multiplicity-adjusted threshold (q = 0.065) and attenuated when first-week infections were excluded. Conclusions: Documented infections and infection-related deaths were frequent in this heterogeneous cohort, but uncertain onset limits the interpretation of the early cluster. The albumin finding is hypothesis-generating and does not establish prediction or causation.
- 28 October 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1694
Open AccessDocumented Infections and Mortality in Patients Receiving Bruton Tyrosine Kinase Inhibitors: A Single-Center Retrospective Cohort of B-Cell Malignancies and Chronic Graft-Versus-Host Disease
Background/Objectives: Infection burden during Bruton tyrosine kinase inhibitor (BTKi) treatment is difficult to interpret when infection onset, treatment initiation, and discontinuation are incompletely documented. We described the timing, microbiology, and mortality of documented infections and explored the association between peri-initiation albumin and documented infection. Methods: This retrospective single-center cohort included 76 patients treated with ibrutinib or acalabrutinib for B-cell malignancies or chronic graft-versus-host disease (cGVHD). The first documented on-treatment infection was analyzed using Aalen–Johansen cumulative incidence, with death or permanent treatment discontinuation as competing events. Sensitivity analyses included a day-30 landmark analysis, a total-burden analysis that also counted infections after discontinuation, and indication-specific estimates. Albumin associations were assessed through day 90, with Benjamini–Hochberg correction across seven exploratory comparisons. Results: Fifty-eight patients had B-cell malignancies and 18 had cGVHD; median follow-up by reverse Kaplan–Meier was 244 days. A qualifying infection occurred in 27/76 patients (35.5%); 17/27 were recorded within 30 days, of which one was suggestive of pre-existing infection and 16 were indeterminate. The cumulative incidence at day 180 was 30.5% (95% CI 19.9–41.5%) on treatment and 38.1% (95% CI 26.2–50.4%) when post-discontinuation infections were included. Among 49 patients still eligible at day 30, the conditional incidence by original day 180 was 11.2% (95% CI 2.4–21.3%). Respiratory and urinary foci accounted for 13/27 and 9/27 infections, respectively. Twenty-nine patients (38.2%) died; 17/29 deaths were recorded as infection-related. Median albumin was lower in patients with infection by day 90 (3.05 versus 3.80 g/dL; nominal p = 0.009), but this exploratory difference did not meet the multiplicity-adjusted threshold (q = 0.065) and attenuated when first-week infections were excluded. Conclusions: Documented infections and infection-related deaths were frequent in this heterogeneous cohort, but uncertain onset limits the interpretation of the early cluster. The albumin finding is hypothesis-generating and does not establish prediction or causation.
- Open Access
- 27 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2459
Blood Culture-Based Classification of Early Bacterial Bloodstream Infection After Autologous Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
Estimates of early bacterial bloodstream infection (BSI) after autologous hematopoietic stem cell transplantation (HSCT) depend on the classification of common commensals. We examined the sensitivity of BSI frequency and microbiology to three operational definitions. This retrospective single-center cohort comprised 161 autologous transplant episodes in 158 patients from September 2015 to February 2026. The endpoint covered day 0–30. A permissive rule counted any bacterial growth. The primary definition excluded CoNS-only episodes classified as contamination following retrospective review of blood culture results and clinical records. A restrictive definition additionally excluded episodes with sole viridans-group or unspeciated streptococci or Corynebacterium. Formal adjudication according to the full National Healthcare Safety Network surveillance criteria was not performed. Regression and survival analyses were exploratory. The proportions meeting the permissive, primary, and restrictive endpoints were 56.5% (91/161), 23.6% (38/161; 95% confidence interval 17.3–30.9), and 21.1% (34/161), respectively. The primary definition included 40 isolates, of which 27 (67.5%) were Gram-negative and 21 (52.5%) were Escherichia coli. Gram-positive isolates predominated under the permissive rule (71.0%). Exploratory regression estimates were imprecise. In the day-30 landmark survival analysis, the operational BSI classification was inversely associated with subsequent mortality; however, this finding was based on only four deaths in the BSI-classified group and remained vulnerable to survivor selection, residual confounding, and exposure misclassification. Reported BSI frequency and organism distribution were sensitive to commensal classification. Explicit operational definitions, retrospective clinical assessment of CoNS isolates, and sensitivity analyses aid interpretation; however, the absence of standardized surveillance adjudication limits the estimation of true BSI incidence. The survival findings require cautious, noncausal interpretation.
- 27 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2459
Open AccessBlood Culture-Based Classification of Early Bacterial Bloodstream Infection After Autologous Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
Estimates of early bacterial bloodstream infection (BSI) after autologous hematopoietic stem cell transplantation (HSCT) depend on the classification of common commensals. We examined the sensitivity of BSI frequency and microbiology to three operational definitions. This retrospective single-center cohort comprised 161 autologous transplant episodes in 158 patients from September 2015 to February 2026. The endpoint covered day 0–30. A permissive rule counted any bacterial growth. The primary definition excluded CoNS-only episodes classified as contamination following retrospective review of blood culture results and clinical records. A restrictive definition additionally excluded episodes with sole viridans-group or unspeciated streptococci or Corynebacterium. Formal adjudication according to the full National Healthcare Safety Network surveillance criteria was not performed. Regression and survival analyses were exploratory. The proportions meeting the permissive, primary, and restrictive endpoints were 56.5% (91/161), 23.6% (38/161; 95% confidence interval 17.3–30.9), and 21.1% (34/161), respectively. The primary definition included 40 isolates, of which 27 (67.5%) were Gram-negative and 21 (52.5%) were Escherichia coli. Gram-positive isolates predominated under the permissive rule (71.0%). Exploratory regression estimates were imprecise. In the day-30 landmark survival analysis, the operational BSI classification was inversely associated with subsequent mortality; however, this finding was based on only four deaths in the BSI-classified group and remained vulnerable to survivor selection, residual confounding, and exposure misclassification. Reported BSI frequency and organism distribution were sensitive to commensal classification. Explicit operational definitions, retrospective clinical assessment of CoNS isolates, and sensitivity analyses aid interpretation; however, the absence of standardized surveillance adjudication limits the estimation of true BSI incidence. The survival findings require cautious, noncausal interpretation.
- 1 February 2011
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 104 (2) , 156
Response to “Cerebrospinal Fluid Viscosity: Can It Be Used as a Novel Diagnostic Measure for Acute Meningitis?”
To the Editor: We would like to thank Drs. Hong-Liang Zhang and Jiang Wu for their valuable comments on our paper, “Cerebrospinal Fluid Viscosity: A Novel Diagnostic Measure for Acute Meningitis” (South Med J 2010 Sep; 103(9): 892–5).1 Briefly, they have commented on the result of cerebrospinal fluid (CSF) viscosity and CSF protein levels and their correlation, pointing out that all of...
- 1 February 2011
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 104 (2) , 156
Response to “Cerebrospinal Fluid Viscosity: Can It Be Used as a Novel Diagnostic Measure for Acute Meningitis?”
To the Editor: We would like to thank Drs. Hong-Liang Zhang and Jiang Wu for their valuable comments on our paper, “Cerebrospinal Fluid Viscosity: A Novel Diagnostic Measure for Acute Meningitis” (South Med J 2010 Sep; 103(9): 892–5).1 Briefly, they have commented on the result of cerebrospinal fluid (CSF) viscosity and CSF protein levels and their correlation, pointing out that all of...
- 1 January 2011
- Vol. 45 (1) , 28-35
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Infections caused by extended-spectrum beta-lactamase (ESBL) producing Escherichia coli and Klebsiella spp. constitute severe problems. Carbapenems are commonly used to treat these infections. However, infections caused by carbapenem-resistant gram-negative bacteria show an increasing trend recently. The aim of this study was to investigate the susceptibilities of ESBL-producing E.coli and Klebsiella spp. to ertapenem and other carbapenems. A total of 239 E.coli, 28 K.pneumoniae and 11 K.oxytoca strains isolated from clinical specimens (208 urine, 16 blood, 26 wound, 17 sterile body fluids, four tracheal aspirates and seven others) of hospitalized patients and outpatients between January 2007-February 2008, were included to the study. The isolates were identified by conventional methods, and antibiotic susceptibility tests were performed by Kirby Bauer disc diffusion method according to Clinical and Laboratory Standards Institute (CLSI) standards. ESBL production was tested by double disk diffusion method. When ESBL production was indeterminate, cefotaxime-clavulanic acid E test (BioMerieux, France) was used. According to the CLSI standards modified Hodge test was performed for carbapenem resistant isolates and minimal inhibitory concentration (MIC) values were detected for ertapenem (Etest®, BioMerieux, France), imipenem and meropenem (M.I.C. Evaluator Strips, Oxoid, UK). All of the isolates were found susceptible to amikacin (278/278; 100%), whereas the susceptibility rates for imipenem/meropenem and ertapenem were 99.3% (276/278) and 98.6% (274/278), respectively. When evaluated individually, ertapenem susceptibilities of E.coli, K.pneumoniae and K.oxytoca strains were 99.2%, 96.4% and 90.9%, respectively, while these rates were 100%, 96.4% and 90.9%, respectively, for imipenem/meropenem. Carbapenem resistance was detected in two E.coli, one K.oxytoca and one K.pneumoniae isolates. While two Klebsiella spp. İsolates were resistant to all of the tested carbapenems (MIC > 32 µg/ml), two E.coli isolates were resistant to ertapenem (MIC > 32 µg/ml) but susceptible to imipenem (MIC= 0.25 µg/ml) and meropenem (MIC= 0.5 µg/ml). Carbapenemase production was demonstrated by modified Hodge test in all of the carbapenem-resistant isolates. In conclusion, ESBL-producing gram-negative isolates should be routinely tested with a screening method for carbapenemase activity and confirmation tests should be performed in suspected cases.
- 1 January 2011
- Vol. 45 (1) , 28-35
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Infections caused by extended-spectrum beta-lactamase (ESBL) producing Escherichia coli and Klebsiella spp. constitute severe problems. Carbapenems are commonly used to treat these infections. However, infections caused by carbapenem-resistant gram-negative bacteria show an increasing trend recently. The aim of this study was to investigate the susceptibilities of ESBL-producing E.coli and Klebsiella spp. to ertapenem and other carbapenems. A total of 239 E.coli, 28 K.pneumoniae and 11 K.oxytoca strains isolated from clinical specimens (208 urine, 16 blood, 26 wound, 17 sterile body fluids, four tracheal aspirates and seven others) of hospitalized patients and outpatients between January 2007-February 2008, were included to the study. The isolates were identified by conventional methods, and antibiotic susceptibility tests were performed by Kirby Bauer disc diffusion method according to Clinical and Laboratory Standards Institute (CLSI) standards. ESBL production was tested by double disk diffusion method. When ESBL production was indeterminate, cefotaxime-clavulanic acid E test (BioMerieux, France) was used. According to the CLSI standards modified Hodge test was performed for carbapenem resistant isolates and minimal inhibitory concentration (MIC) values were detected for ertapenem (Etest®, BioMerieux, France), imipenem and meropenem (M.I.C. Evaluator Strips, Oxoid, UK). All of the isolates were found susceptible to amikacin (278/278; 100%), whereas the susceptibility rates for imipenem/meropenem and ertapenem were 99.3% (276/278) and 98.6% (274/278), respectively. When evaluated individually, ertapenem susceptibilities of E.coli, K.pneumoniae and K.oxytoca strains were 99.2%, 96.4% and 90.9%, respectively, while these rates were 100%, 96.4% and 90.9%, respectively, for imipenem/meropenem. Carbapenem resistance was detected in two E.coli, one K.oxytoca and one K.pneumoniae isolates. While two Klebsiella spp. İsolates were resistant to all of the tested carbapenems (MIC > 32 µg/ml), two E.coli isolates were resistant to ertapenem (MIC > 32 µg/ml) but susceptible to imipenem (MIC= 0.25 µg/ml) and meropenem (MIC= 0.5 µg/ml). Carbapenemase production was demonstrated by modified Hodge test in all of the carbapenem-resistant isolates. In conclusion, ESBL-producing gram-negative isolates should be routinely tested with a screening method for carbapenemase activity and confirmation tests should be performed in suspected cases.
- 1 September 2010
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 103 (9) , 892-895
Cerebrospinal Fluid Viscosity: A Novel Diagnostic Measure for Acute Meningitis
Early diagnosis of acute meningitis has paramount importance in clinical practice because of mortality and morbidity of the disease. Examination of cerebrospinal fluid (CSF) has critical value for the diagnosis of acute meningitis and discrimination of bacterial and aseptic meningitis. It has been previously reported that plasma viscosity can be used as an inflammatory marker. In this study we aimed to evaluate the role of CSF viscosity as a complementary measure for diagnosis of meningitis in suspected patients. Forty-one consecutive patients who underwent lumbar puncture to rule out meningitis were studied prospectively. Twenty-seven patients were diagnosed with meningitis, of whom 13 patients had aseptic meningitis and 14 patients had bacterial meningitis. Meningitis was ruled out in 14 patients. CSF protein and CSF viscosity were significantly higher in patients with meningitis compared to nonmeningitis. Receiver operator characteristic (ROC) analysis revealed that CSF viscosity was highly sensitive (100%) and specific (93%); measures for the diagnosis of meningitis in the study population was comparable to those of CSF protein. Additionally, patients with meningitis were also divided into two groups as having bacterial and aseptic meningitis. CSF viscosity also significantly differed between bacterial and aseptic meningitis. The CSF viscosity is a simple and easy method and can be used as an adjunctive measure for the diagnosis of meningitis. With the support of further and larger clinical studies, CSF viscosity may have a role in the discrimination of bacterial versus aseptic meningitis.
- 1 September 2010
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 103 (9) , 892-895
Cerebrospinal Fluid Viscosity: A Novel Diagnostic Measure for Acute Meningitis
Early diagnosis of acute meningitis has paramount importance in clinical practice because of mortality and morbidity of the disease. Examination of cerebrospinal fluid (CSF) has critical value for the diagnosis of acute meningitis and discrimination of bacterial and aseptic meningitis. It has been previously reported that plasma viscosity can be used as an inflammatory marker. In this study we aimed to evaluate the role of CSF viscosity as a complementary measure for diagnosis of meningitis in suspected patients. Forty-one consecutive patients who underwent lumbar puncture to rule out meningitis were studied prospectively. Twenty-seven patients were diagnosed with meningitis, of whom 13 patients had aseptic meningitis and 14 patients had bacterial meningitis. Meningitis was ruled out in 14 patients. CSF protein and CSF viscosity were significantly higher in patients with meningitis compared to nonmeningitis. Receiver operator characteristic (ROC) analysis revealed that CSF viscosity was highly sensitive (100%) and specific (93%); measures for the diagnosis of meningitis in the study population was comparable to those of CSF protein. Additionally, patients with meningitis were also divided into two groups as having bacterial and aseptic meningitis. CSF viscosity also significantly differed between bacterial and aseptic meningitis. The CSF viscosity is a simple and easy method and can be used as an adjunctive measure for the diagnosis of meningitis. With the support of further and larger clinical studies, CSF viscosity may have a role in the discrimination of bacterial versus aseptic meningitis.
- 1 January 2003
- Published by Ankara University in Journal of Ankara Medical School
- p. 1-4
VALUE OF PLASMA VISCOCITY AS AN ACUTE PHASE REACTANT IN PATIENTS WITH PNEUMONIA
- 1 January 2003
- Published by Ankara University in Journal of Ankara Medical School
- p. 1-4
VALUE OF PLASMA VISCOCITY AS AN ACUTE PHASE REACTANT IN PATIENTS WITH PNEUMONIA